A voter-passed measure to expand Medicaid coverage in Missouri will not advance; $7.4 billion will soon be available for recruiting and hiring public health workers; the World Health Organization (WHO) is being chastised for its COVID-19 origins report.
MO HealthNet, Missouri’s state Medicaid program, will not be expanding, reports NPR. At present, childless adults do not qualify for coverage under MO HealthNet and a family of 3 must earn below 21% of the federal poverty level (FPL). The preliminary measure, passed by voters last August, would have raised the qualifying limit to 138% of the FPL. Among those asking Governor Mike Parson to reconsider is the American Cancer Society, citing patients with cancer “cannot wait for legal battles to access the life-saving coverage that Medicaid expansion provides.”
A total of $7.4 billion will soon be made available to state and local officials to continue to respond to the COVID-19 pandemic and prepare for similar public health emergencies down the line, according to Bloomberg. Of this total, $4.4 billion will come from the American Rescue Plan and fund the hiring of public health specialists, while $3 billion will be doled out by the CDC to enable underfunded health departments to fund current staff positions and hire additional bodies. Undergraduate student internships, too, will be covered by $337 million that will finance their hiring in public health laboratories.
A letter appearing online today in Science lays out the concerns shouldered by the World Health Organization’s (WHO) director general, the United States, the European Union, and 13 other countries that the WHO’s report on the origins of the COVID-19 pandemic falls short. This international group of 18 biologists, immunologists, and other scientists is asking for a more extensive investigation into how the pandemic began, with The Wall Street Journal noting their claims the original report provided no definitive conclusions on an animal or lab-accident origin to the pandemic in Wuhan, China.
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
For Neuromuscular Disease Community, an Era of Opportunities and Threats
March 17th 2025Robert Califf, MD, former commissioner of the FDA, delivered a keynote address at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference that highlighted the enormous opportunities for progress in neuromuscular disease care amid a changing policy environment.
Read More
The Impact of Cost Sharing on High-Value Care
March 14th 2025Michael Chernew, PhD, professor of health care policy and director of the Healthcare Markets and Regulation Lab, Harvard Medical School, shares how cost-sharing policies shape access to critical health care services and influence value-based insurance design.
Read More
Oz Confirmation Hearing Probes Vision for Medicaid but Coalesces Around Well-Being
March 14th 2025Mehmet Oz, MD, the nominee to lead CMS under the Trump administration, testified in a confirmation hearing before the Senate Finance Committee, where he found common ground on improving outcomes through healthier lifestyle choices but encountered repeated questions on potential Medicaid cuts.
Read More